As the percentage of the global population over 65 continues to increase, the popularity of anti-aging stocks is rising in ...

"On behalf of Vaxart and its Board, I would like to thank Bob for his years of service and contributions to our Company,” said Vaxart Board Chairman, Dr. Michael J. Finney.

GSK has reached an agreement that it says will resolve 93% of the outstanding lawsuits brought against the company claiming that its gastrointestinal drug Zantac caused cancer. The company has ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Teva Pharmaceutical Industries Ltd. ADR 0.46% $24.53B ...

Jacob Roach / Digital Trends Table of Contents Table of Contents The times, they are a- Some simple fixes The Steam Deck Verified program was a good start, but it’s time to move on. Valve ...

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

GSK licensed the drug from long-standing partner Ionis as part of a two-drug deal in 2019, paying $25 million upfront with milestone payments taking the value of the deal up to $262 million.

After hours: January 24 at 7:46:59 p.m. EST ...

At close: January 23 at 4:00:02 PM EST ...

Involves transaction of at least 0.5% of the listed shares of a company. What was Glaxosmithkline Pharmaceuticals Ltd share price previously? Glaxosmithkline Pharmaceuticals Ltd share price was ...